Andlauer Healthcare Group, Inc. (TSE:AND) has released an update.
Andlauer Healthcare Group, Inc. has reported a slight increase in Q4 2023 revenue to $169.1 million with a steady EBITDA, but faced a year-over-year decline in net income and EBITDA margin for both the quarter and the full year. Despite the fall in U.S. truckload businesses, the company notes a stable market and solid growth in its Canadian operations, with a strategic focus on expanding its healthcare transportation and logistics platform.
For further insights into TSE:AND stock, check out TipRanks’ Stock Analysis page.
